{{Rsnum
|rsid=696
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=14
|Orientation=minus
|Gene=NFKBIA
|position=35401887
|Gene_s=NFKBIA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.9 | 46.0 | 38.1
| HCB | 16.5 | 47.4 | 36.1
| JPT | 7.1 | 38.4 | 54.5
| YRI | 50.7 | 43.2 | 6.2
| ASW | 31.6 | 45.6 | 22.8
| CHB | 16.5 | 47.4 | 36.1
| CHD | 20.2 | 44.0 | 35.8
| GIH | 12.9 | 50.5 | 36.6
| LWK | 34.3 | 50.0 | 15.7
| MEX | 10.3 | 46.6 | 43.1
| MKK | 34.8 | 47.7 | 17.4
| TSI | 14.7 | 48.0 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=24971461
|Title=Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort
}}

{{PMID Auto
|PMID=25223483
|Title=Effect of functional nuclear factor kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}